These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 6975478)
21. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia. Schwartz SA; Morgenstern B; Capizzi RL Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600 [TBL] [Abstract][Full Text] [Related]
22. Dose-dependent cytokinetic changes following 1-beta-D-arabinofuranosylcytosine and hydroxyurea in L1210 and S-180 in vivo. Straus MJ; Moran RE Cell Tissue Kinet; 1978 Sep; 11(5):529-42. PubMed ID: 299719 [TBL] [Abstract][Full Text] [Related]
23. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60). Vilpo JA; Vilpo LM Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271 [TBL] [Abstract][Full Text] [Related]
24. Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloid leukemia after repeated treatment with ara-C in vivo. Chiba P; Tihan T; Szekeres T; Salamon J; Kraupp M; Eher R; Köller U; Knapp W Leukemia; 1990 Nov; 4(11):761-5. PubMed ID: 2232889 [TBL] [Abstract][Full Text] [Related]
25. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells. Lauzon GJ; Paran JH; Paterson AR Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174 [TBL] [Abstract][Full Text] [Related]
26. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA. Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273 [TBL] [Abstract][Full Text] [Related]
27. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin. Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997 [TBL] [Abstract][Full Text] [Related]
28. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine. Ross DD; Cuddy DP; Cohen N; Hensley DR Cancer Chemother Pharmacol; 1992; 31(1):61-70. PubMed ID: 1458561 [TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine. Bhalla K; Nayak R; Grant S Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
31. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine. Liliemark JO; Plunkett W; Dixon DO Cancer Res; 1985 Nov; 45(11 Pt 2):5952-7. PubMed ID: 4053067 [TBL] [Abstract][Full Text] [Related]
32. Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosine. Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR Biochem Pharmacol; 1984 Apr; 33(7):1059-63. PubMed ID: 6712715 [TBL] [Abstract][Full Text] [Related]
33. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines. Ramilo-Torno LV; Avramis VI Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176 [TBL] [Abstract][Full Text] [Related]
34. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells. Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999 [TBL] [Abstract][Full Text] [Related]
36. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells. Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR Cancer Treat Rep; 1985; 69(7-8):851-7. PubMed ID: 4016794 [TBL] [Abstract][Full Text] [Related]
37. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia. Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275 [TBL] [Abstract][Full Text] [Related]
38. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking. Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295 [TBL] [Abstract][Full Text] [Related]
39. Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia. Danhauser L; Plunkett W; Liliemark J; Gandhi V; Iacoboni S; Keating M Leukemia; 1987 Sep; 1(9):638-43. PubMed ID: 3478543 [TBL] [Abstract][Full Text] [Related]
40. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells. Lauzon GJ; Paterson AR; Belch AW Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]